(19)
(11) EP 4 103 208 A1

(12)

(43) Date of publication:
21.12.2022 Bulletin 2022/51

(21) Application number: 21754580.5

(22) Date of filing: 12.02.2021
(51) International Patent Classification (IPC): 
A61K 35/74(2015.01)
A61K 39/39(2006.01)
A61K 39/04(2006.01)
C12N 15/70(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/74; A61K 39/04; C12N 15/70; A61K 39/39; C12N 15/74; A61K 2039/523; A61K 2039/55594; A61K 2039/54; A61P 35/00
(86) International application number:
PCT/US2021/018007
(87) International publication number:
WO 2021/163602 (19.08.2021 Gazette 2021/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.02.2020 US 202016790161

(71) Applicant: The Johns Hopkins University
Baltimore, Maryland 21218 (US)

(72) Inventors:
  • BISHAI, William, R.
    Baltimore, Maryland 21231 (US)
  • BIVALACQUA, Trinity, J.
    Baltimore, Maryland 21210 (US)
  • SINGH, Alok
    Baltimore, Maryland 21231 (US)
  • PRAHARAJ, Monali
    Baltimore, Maryland 21231 (US)
  • YOSHIDA, Takahiro
    Baltimore, Maryland 21218 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER